Description
Experience the transformative power of Kerastase Specifique Aminexil Cure Anti-Chute, a conditioning and protective hair treatment specially formulated to address thinning hair and hair loss. Enriched with glucolipid gL for hydration and protection, Madecassoside Molecule-M to soothe the scalp, and Aminexil to improve hair density and reduce hair loss. This intensive treatment is recommended for a duration of six weeks for optimal results.
Benefits
Clinically proven to help reducing the rate of hair loss*
Offers better resistance to traction and less breakage during styling
Hair is enhanced, thicker and stronger
It recaptures volume, shine and flexibility
Hair is silky. No grease on the roots
*Clinical test. 119/130 people vs placebo. Daily application for 6 weeks.
Key Ingredients
Aminexil 15 000 PPM (INCI name Diaminopyrimidine Oxide): Originally used to treat high blood pressure, Amenixil compounds came into use for alopecia therapy when it was discovered that a side effect of taking the blood pressure treatment was increased body hair.
The valuable blend of Aminexil®, GlucoLipide GL® and Madecassoside help maintain hair density*. It improves the heath of tissues surrounding the hair root making them more flexible and resilient which allows the root to anchor more firmly into the scalp.
Rhamnose: A vegetable sugar with anti-ageing properties responsible for the production of collagen and elastin that provide support and flexibility to the skin.
Complexe AOX: To protect from oxidative stress.
*Clinical test. 119/130 people vs placebo. Daily application for 6 weeks.
How To Use
The box contains 42 x 6ml vials of hair treatment; simply apply one vial per day to dry hair or hair that has been towel dried. Apply 3 times a week for 6 weeks. One dose is equal to one application. Distribute in sections. Massage into the scalp using finger tips. Leave in. Style as usual.
Efficiency measured from the first week of use:
The hair-loss is slowed significantly down for 85% of users **
Reduced hair loss while brushing for 90% of users **
** Self-assessment of 124 people, after 7 days of application.